Oep Singapore
Orient EuroPharma Singapore (OEP SG) was established in 1993, with an emphasis on products for prescription drugs and nutritional market. The company showed advantages in oncology, urology, neuroscience, and basic medicine. OEP SG markets products including Navelbine (in injection and capsule form) for non-small cell lung cancer and breast carcinoma; anti-parkinson's disease drug; and Pamorelin® for prostatic cancer. In 2018, the Wealth Magazine in Taiwan announced the Top 100 Taiwanese Business in ASEAN. The subsidiary in Singapore was ranked 88th in the 2015 and 2016 Top 100 Taiwanese Business in ASEAN for revenue and profit growth, and its business results have been recognized by external communities.
7-day free trial · no credit card
Verified contacts
3
available on Kipplo
LinkedIn employees
3
11 to 50 range
Open roles
—
no listings
Distinct roles
3
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 3 verified contacts at Oep Singapore
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
3 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Oep Singapore
3 distinct titles indexed · top 3 shown.
- 1account executive
- 1customer engagement executive
- 1head of pharma
Sign up to unlock all 3 contacts at Oep Singapore
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 3 verified contacts at Oep Singapore
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.